
|Articles|December 4, 2015
New Biosimilar Under Review in Top Specialty Pharmacy News
Author(s)Davy James, Managing Editor
Catch up with any news you missed this week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/new-biosimilar-under-review-in-top-specialty-pharm" target="_blank">View the story "New Biosimilar Under Review in Top Specialty Pharmacy News" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
3
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
4
Workforce Preparation for Fall Immunization Season Starts Now
5






































































































